Bambusa completes patient enrollment for BBT001 atopic dermatitis trial
May 01, 2026 | 13:19
The biotech firm finished recruiting participants for a Phase 1b/2a trial of BBT001, a potential treatment for atopic dermatitis.
Mobile Version